If you need more lookups,
subscriptions start at $34 USD/month.
Maria Törnsén Location
Boston, MA, US
Maria Törnsén Work
Chief Operating Officer (COO) and President US @ (May 2025 - Present)
Board Member @ (July 2022 - Present)
President North America @ (January 2024 - April 2025)
Chief Commercial Officer (CCO) @ (July 2021 - December 2022)
Senior Vice President, General Manager US @ (February 2021 - July 2021)
VP General Manager and Head of US Commercial @ (August 2019 - February 2021)
VP Global Therapeutic Area Head Rare Diseases @ (July 2017 - July 2019)
Vice President, Head of US Sales @ (January 2017 - May 2017)
Vice President, Head of US Sales and Marketing @ (June 2016 - December 2016)
Senior Director, Head of US Marketing @ (August 2015 - May 2016)
Senior Director International Marketing @ (February 2015 - July 2015)
Director International Marketing Disease Awareness and Commercial Excellence @ (February 2014 - January 2015)
Director Global Marketing, Rare Disease @ (February 2013 - February 2014)
Associate Director Global Marketing, Rare Disease @ (April 2012 - February 2013)
Associate Product Director EMEA, Rare Disease @ (July 2011 - April 2012)
Associate Director Global Marketing @ (February 2010 - June 2011)
Senior Marketing Manager Global Marketing @ (May 2009 - February 2010)
Marketing Manager Global Marketing @ (April 2008 - May 2009)
Product Manager @ (December 2006 - March 2008)
Key Account Manager @ (January 2006 - December 2006)
Product Specialist and Sales Representative @ Eli Lilly and Company (July 2002 - December 2005)
Maria Törnsén Education
Lund University
Master of Science - MS (Business Administration and Management, General)
1998-2002
Maria Törnsén Skills
Nephrology
Medical Affairs
Investor Relations
Commercialization
Psychiatry
global marketing
country marketing
Endocrinology
Neurology
Global Alliance Management
Portfolio Management
Audit Committee
Executive Compensation Planning
Business Strategy
Strategic Planning
Program Management
Drug Development
Teamwork
Team Leadership
Resource Allocation
Regulatory Requirements
Industry standards
Biopharmaceuticals
Product Launch
Strategy
Management
Sales
Board of Directors
Leadership
P&L Management
Problem Solving
Decision-Making
Resiliency
Organizational Effectiveness
Product Strategy
Communication
Rare Diseases
Gene Therapy
Cross-functional Team Leadership
Active Listening
Coaching & Mentoring
Competitive Analysis
Key Account Management
Diabetes
Pharmaceuticals
Pharmaceutical Sales
Product Launches
Product Management
Marketing Communications
Product Marketing
Marketing Management
Orphan Drugs
CNS disorders
Vendor Management
Marketing Budget Management
Biotechnology
Sales Management
People Management
Training
Sales Effectiveness
Microsoft Word
Account Management
Brand Management
Microsoft Excel
Cross Functional Team Leadership
Market Access
Maria Törnsén Summary
Maria Törnsén, based in Boston, MA, US, is currently a Chief Operating Officer (COO) and President US at Hansa Biopharma. Maria Törnsén brings experience from previous roles at Immunic Therapeutics, Calliditas Therapeutics, Passage Bio and Sarepta Therapeutics. Maria Törnsén holds a 1998 - 2002 Master of Science - MS in Business Administration and Management, General @ Lund University. With a robust skill set that includes Nephrology, Medical Affairs, Investor Relations, Commercialization, Psychiatry and more. Maria Törnsén has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Maria Törnsén?
Find contact details for 700 million professionals.